Clinical Trial Update: Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing cilostazol to aspirin for vascular dementia in post-stroke patients with white matter lesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Vascular Dementia

Drugs mentioned

• Aspirin (Aspirin)
• Cilostazol (Cilostazol)

Snippet

Sponsor: Peking University First Hospital | Conditions: Vascular Dementia, Stroke | Phase 4 | Status: COMPLETED